J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 75 (1994), 85-94; DOI 10.1099/0022-1317-75-1-85
© 1994 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gratama, J. W.
Right arrow Articles by Ernberg, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gratama, J. W.
Right arrow Articles by Ernberg, I.
Agricola
Right arrow Articles by Gratama, J. W.
Right arrow Articles by Ernberg, I.

Detection of multiple ‘Ebnotypes’ in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx

J. W. Gratama1, M. A. P. Oosterveer1, W. Weimar4, K. Sintnicolaas3, W. Sizoo2, R. L. H. Bolhuis1 and I. Ernberg5

1 Department of Clinical and Tumour Immunology
and2 Department of Haematology
and3 Department of Blood Transfusion Service, Daniel den Hoed Cancer Centre
4 Department of Internal Medicine I, University Hospital Dijkzigt, Rotterdam, The Netherlands
and5 Department of Virology, Karolinska Institute, Stockholm, Sweden

Transformation of a B lymphocyte into a lymphoblastoid cell line (LCL) by Epstein-Barr virus (EBV) results in the expression of EBV nuclear antigens (EBNAs) of which the size spectrum (‘Ebnotype’) is characteristic for the transforming virion. Ebnotyping has been used as an epidemiological tool for studies of EBV infection. We compared the occurrence of a single and of multiple Ebnotypes, as defined by EBNAs 1, 2 and 6, in healthy and diseased EBV carriers. Cases from which two or more LCLs could be established from peripheral blood or oropharyngeal cultures were considered informative. The frequency of multiple Ebnotypes was relatively low in healthy individuals and in patients with infectious mononucleosis or with haematological diseases who were awaiting a bone marrow transplant [blood, 11 of 74 patients (15%); oropharynx, 12 of 49 patients (24%)], whereas it was relatively high in recipients of bone marrow or cardiac allografts and one patient with AIDS [blood, 12 of 34 patients (35%); oropharynx, 11 of 16 patients (69%)]. Three patterns of the simultaneous presence of multiple Ebnotypes were distinguished. The first, most frequent, pattern observed predominantly in oropharyngeal cultures of all groups consisted of minority Ebnotypes differing from the majority type by only a single EBNA protein (usually EBNA 1). The second, less frequent, pattern observed in the healthy carriers and the (candidate) transplant recipients consisted of minority Ebnotypes differing from the majority type by two EBNA proteins (mostly EBNAs 1 and 6). The third pattern, characterized by the simultaneous presence of totally different Ebnotypes, was restricted to the (candidate) transplant recipients and the AIDS patient and was more frequently observed in the blood than in the oropharynx. We suggest that the first two patterns result from heterologous recombinations occurring during viral replication at repeat sequences within the EBNA coding regions, whereas the third pattern reflects multiple infections with exogenous viruses.

Received 8 July 1993; accepted 7 September 1993.


This article has been cited by other articles:


Home page
CVIHome page
S. Harada, Y. Kamata, Y. Ishii, H. Eda, R. Kitamura, M. Obayashi, S. Ito, F. Ban, J. Kuranari, H. Nakajima, et al.
Maintenance of Serum Immunoglobulin G Antibodies to Epstein-Barr Virus (EBV) Nuclear Antigen 2 in Healthy Individuals from Different Age Groups in a Japanese Population with a High Childhood Incidence of Asymptomatic Primary EBV Infection
Clin. Vaccine Immunol., January 1, 2004; 11(1): 123 - 130.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. M. Walling, A. L. Brown, W. Etienne, W. A. Keitel, and P. D. Ling
Multiple Epstein-Barr Virus Infections in Healthy Individuals
J. Virol., June 1, 2003; 77(11): 6546 - 6550.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Sitki-Green, R. H. Edwards, J. Webster-Cyriaque, and N. Raab-Traub
Identification of Epstein-Barr Virus Strain Variants in Hairy Leukoplakia and Peripheral Blood by Use of a Heteroduplex Tracking Assay
J. Virol., August 28, 2002; 76(19): 9645 - 9656.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. M. Brooks, D. S. G. Croom-Carter, A. M. Leese, R. J. Tierney, G. Habeshaw, and A. B. Rickinson
Cytotoxic T-Lymphocyte Responses to a Polymorphic Epstein-Barr Virus Epitope Identify Healthy Carriers with Coresident Viral Strains
J. Virol., February 15, 2000; 74(4): 1801 - 1809.
[Abstract] [Full Text]


Home page
J. Virol.Home page
R. S. Midgley, N. W. Blake, Q. Y. Yao, D. Croom-Carter, S. T. Cheung, S. F. Leung, A. T. C. Chan, P. J. Johnson, D. Huang, A. B. Rickinson, et al.
Novel Intertypic Recombinants of Epstein-Barr Virus in the Chinese Population
J. Virol., February 1, 2000; 74(3): 1544 - 1548.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A. J. Aguirre and E. S. Robertson
Epstein-Barr Virus Recombinants from BC-1 and BC-2 Can Immortalize Human Primary B Lymphocytes with Different Levels of Efficiency and in the Absence of Coinfection by Kaposi's Sarcoma-Associated Herpesvirus
J. Virol., January 1, 2000; 74(2): 735 - 743.
[Abstract] [Full Text]


Home page
J. Virol.Home page
Y.-G. Cho, A. V. Gordadze, P. D. Ling, and F. Wang
Evolution of Two Types of Rhesus Lymphocryptovirus Similar to Type 1 and Type 2 Epstein-Barr Virus
J. Virol., November 1, 1999; 73(11): 9206 - 9212.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Habeshaw, Q. Y. Yao, A. I. Bell, D. Morton, and A. B. Rickinson
Epstein-Barr Virus Nuclear Antigen 1 Sequences in Endemic and Sporadic Burkitt's Lymphoma Reflect Virus Strains Prevalent in Different Geographic Areas
J. Virol., February 1, 1999; 73(2): 965 - 975.
[Abstract] [Full Text]


Home page
J. Virol.Home page
Q. Y. Yao, D. S. G. Croom-Carter, R. J. Tierney, G. Habeshaw, J. T. Wilde, F. G. H. Hill, C. Conlon, and A. B. Rickinson
Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2: Lessons from the Study of a T-Cell-Immunocompromised Hemophilic Cohort
J. Virol., May 1, 1998; 72(5): 4352 - 4363.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Sandvej, J. W. Gratama, M. Munch, X.-G. Zhou, R. L.H. Bolhuis, B. Storstein Andresen, N. Gregersen, and S. Hamilton-Dutoit
Sequence Analysis of the Epstein-Barr Virus (EBV) Latent Membrane Protein-1 Gene and Promoter Region: Identification of Four Variants Among Wild-Type EBV Isolates
Blood, July 1, 1997; 90(1): 323 - 330.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1994 by the Society for General Microbiology.